|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2008-9-1
|
|
pubmed:abstractText |
The association of the -675 4G/5G polymorphism of the plasminogen activator inhibitor-1 (PAI-1) gene with cardiovascular disease in patients with type 2 diabetes (T2DM) is unknown.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0009-8981
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
396
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
18-22
|
|
pubmed:meshHeading |
pubmed-meshheading:18619429-Angiography,
pubmed-meshheading:18619429-Coronary Artery Disease,
pubmed-meshheading:18619429-Diabetes Complications,
pubmed-meshheading:18619429-Diabetes Mellitus, Type 2,
pubmed-meshheading:18619429-Disease-Free Survival,
pubmed-meshheading:18619429-Female,
pubmed-meshheading:18619429-Genotype,
pubmed-meshheading:18619429-Humans,
pubmed-meshheading:18619429-Male,
pubmed-meshheading:18619429-Middle Aged,
pubmed-meshheading:18619429-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:18619429-Polymorphism, Genetic,
pubmed-meshheading:18619429-Risk Factors
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Type 2 diabetes significantly modulates the cardiovascular risk conferred by the PAI-1 -675 4G/5G polymorphism in angiographied coronary patients.
|
|
pubmed:affiliation |
Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), Feldkirch, Austria.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
